Originally launched in 2006, the BHIVA Research Awards are open, through competitive application, to all BHIVA members for research projects that impact on the improvement of clinical care and management of people living with HIV in the UK. A minimum of £30,000 per annum is available, to be distributed amongst the successful applicants according to the quality of the submitted proposals, with a maximum of £10,000 award per application. The awards panel is chaired by an independent chair and the call for applications is usually announced in June and successful applicants notified in October.
Applications for grants or funding for research or other projects made directly to the Association are reviewed by the BHIVA Executive Committee at its meetings and considered based on merit and their relevance to the objectives of BHIVA.
BHIVA Research Awards 2013 - applications have now closed
BHIVA received 21 good quality applications from large and small centres in 2012, requesting a total of £172,983.44. BHIVA is proud to announce the following 6 successful applicants being awarded £50,200.00.
'Drivers and barriers to active recall for HIV testing of MSM at high risk of HIV infection in Genitourinary Medicine clinics', Dr Monica Desai, Health Protection Agency
'Use of Immunocapture and Next Generation Sequencing to Identify the Cellular Origin of Rebound Viraemia following Therapy Cessation in Primary HIV Infection', Dr John Frater, Oxford University
'Evolution of HIV-1 drug resistance in early virological failure of first line non-nucleoside reverse transcriptase inhibitor (NNRTI) -containing regimens', Dr Nicola Mackie, Imperial College Healthcare NHS Trust, London
'Prospective Routine HIV Testing of Patients Presenting with Infectious Mononucleosis-Like Illness to Primary Care Providers in North West London', Dr Michael Rayment, Chelsea and Westminster Hospital NHS Foundation Trust, London
'Towards a cure for HIV: Development of a suite of laboratory assays to assess the HIV reservoir', Miss Sarah Watters, University College London
'Using next generation sequencing to detect low level hepatitis C drug resistance mutations in HIV+ and HIV- HCV patients to predict treatment outcome', Dr Gareth Weedall, University of Liverpool
Don Jeffries Research Award
In 2012, as a memorial to Professor Donald Jeffries CBE, the BHIVA Education and Scientific Subcommittee instituted an award for the top-scoring project in the BHIVA Research Awards applications. This award has been set up in perpetuity, to honour Professor Jeffries' unerring support and dedication to the British HIV Association.
The inaugural Don Jeffries Research Award will be presented to Dr John Frater at the BHIVA Autumn Conference on Friday 5 October 2012, for submitting the highest scoring application in the BHIVA Research Awards 2012.
The BHIVA Research Awards 2012 were part-sponsored by Bristol-Myers Squibb, Gilead Sciences and the MRC Resistance Database.
BHIVA received 22 good quality applications from large and small centres in 2011, requesting a total of £183,393. BHIVA is proud to announce the following 7 successful applicants being awarded £52,179.
'Feasibility and acceptability of repeat home-based HIV saliva testing using self sampling oral swabs in men who have sex with men', Dr S Fidler, Imperial College London
'Do HIV-infected HBV vaccine serological non-responders demonstrate T-cell responsiveness to HBV antigen?' Dr T Lavender, Newcastle upon Tyne Hospitals
'Combined CSF biomarkers of HIV-associated neurocognitive impairment (HAND)', Dr S Nightingale, University of Liverpool
'Renal tubular dysfunction as risk factor for bone loss in HIV positive patients', Dr F Post, King's College Hospital and King's College London
'Antiretroviral use in pregnancy and pre-term delivery: the role of immune activation', Dr C Short, Imperial College London
'Evaluation of mixed base threshold settings of a semi-automated sequence editing programme and standardised editing algorithms for the accuracy in detecting the K103N resistance mutation by using allele specific PCR as gold standard', Dr E Smit, Health Protection Agency, Birmingham
'Relapse after treatment for acute HCV infection in HIV-positive men; viral recrudescence or reinfection?' Dr E Thomson, University of Glasgow
The BHIVA Research Awards 2011 were part-sponsored by Bristol-Myers Squibb and Gilead Sciences.
BHIVA received 22 good quality applications from large and small centres in 2010, requesting a total of £158,782. BHIVA announced the following 8 successful applicants being awarded £58,411 (one award was subsequently withdrawn and funds were allocated to the 2011 awards round).
'Estimating the prevalence of occult hepatitis B infection in HIV-infected Zimbabweans in the UK: a pilot study', Dr David Chadwick, James Cook University Hospital, Middlesbrough
'HIV-1 residual viraemia during long-term suppressive HAART: does it influence the burden of the latent reservoir?' Dr Tim Conibear, Royal Free Hospital NHS Trust, London
'Gender-based violence in HIV positive women attending an inner city clinic: Prevalence and risk fact', Dr Rageshri Dhairyawan, Homerton University Hospital NHS Foundation Trust, London PUBLISHED Intimate partner violence in women living with HIV attending an inner city clinic in the United Kingdom: prevalence and associated factors, HIV Medicine, 13 (Suppl. 1), 1–11
'Evaluation of circulating gut-homing T cells as a marker of HIV-1 progression and immune reconstitution', Dr Lucy Dorrell, Oxford Radcliffe Hospitals NHS Trust
'Activin A: a key regulator of immune activation during HIV-1 infection?' Dr Martin Goodier, Imperial College School of Medicine at Chelsea & Westminster Hospital, London
'Characterisation of mucosally transmitted HIV–1 founder viruses', Dr Ravindra Gupta, University College London
'Low Level viraemia on HAART', Dr Ian Harrison, Royal Free Hospital NHS Trust, London
'A Cardiovascular Risk Algorithm for Young Adults Infected with HIV', Dr Margaret Rhoads, Imperial College School of Medicine, London
The BHIVA Research Awards 2010 were part-sponsored by Abbott Laboratories and Gilead Sciences.
'Characterisation of Neurocognitive Function in Perinatally Acquired HIV Positive Young People', Dr Jane Ashby, St Mary's Hospital, London PUBLISHED Cerebral function in perinatally HIV-infected young adults and their HIV-uninfected sibling controls, HIV Medicine, 12 (Suppl. 1), 1–13
'The effects of early antiretroviral intervention in Primary HIV infection (PHI) on markers of bacterial translocation across the gut', Dr Elizabeth Hamlyn, Imperial College London
'Prevalence of, and factors associated with significant liver disease in HIV-infected patients exposed to didanosine and development of a screening strategy using transient elastography to identify sub-clinical disease', Dr Sarah Logan, Royal Free Hospital, London PUBLISHED Prevalence of, and factors associated with, signiﬁcant liver disease in HIV-infected patients exposed to didanosine (DDI) and development of a screening strategy used to identify subclinical disease, HIV Medicine, 12 (Suppl. 1), 14–86
'Microbial translocation, immune activation and accelerated progression of liver fibrosis in HIV/hepatitis C co-infection', Dr Emma Page, Chelsea and Westminster Hospital, London
'HIV Testing in Non-traditional Settings – The HINTS Study', Dr Michael Rayment, Chelsea and Westminster Hospital, London PUBLISHED HIV testing in the emergency department – reporting one arm of the HIV testing in Non-Traditional Settings (HINTS) study, HIV Medicine, 11 (Suppl. 1), 1–119
'The Clinical Utility of Pulse Wave Velocity as a Measure of Arterial Stiffness in HIV-infected individuals', Dr Marta Boffito, Chelsea and Westminster Hospital, London
'The impact of chemotherapy with cART on cellular and viral resistance in HIV-infected patients with cancer', Dr Marta Boffito, Chelsea and Westminster Hospital, London
'Emerging resistance in patients who discontinue a suppressive NNRTI-containing regimen: detecting low frequency NNRTI resistant mutants by ultra-sensitive real-time PCR and determining their impact on subsequent virological suppression', Dr Ana Garcia‑Diaz, Royal Free Hospital, London. PUBLISHED Drug levels and drug resistance after interruption of NNRTI-based HAART in the SMART trial, HIV Medicine, 12 (Suppl. 1), 1–13
'A cross-sectional analysis of serological markers of cardiovascular risk in HAART-naïve HIV-infected individuals', Dr Mark Nelson, Chelsea and Westminster Hospital, London
'An investigation into the prevalence of oral conditions in paediatric HIV', Dr Steven Welch, Birmingham Heartlands Hospital PUBLISHED A study to assess the oral health of children with HIV and their experiences and attitudes, as reported by parents, HIV Medicine, 13 (Suppl. 1), 13–85
'Evaluating the use of peripheral DEXA scans in the detection of osteoporosis in a population of HIV-infected men', Dr Yvonne Gilleece, Brighton and Sussex University Hospitals NHS Trust PUBLISHED Evaluation of peripheral dual energy X-ray absorptiometry to detect osteoporosis in an HIV-seropositive men population. HIV Medicine,10 (Suppl 1) 1-10)
'A study of HIV and anti-retroviral therapy-related renal tubular toxicity using urinary proteomics and metabonomics', Dr Andrew Hall, University College London
'Study to assess the frequency of persistence of Hepatitis C virus in peripheral blood mononuclear cells of patients with previous HIV / Hepatitis C co-infection', Dr Emma Low, Chelsea and Westminster Hospital, London PUBLISHED The frequency of hepatitis C virus (HCV) persistence in peripheral blood mononueclear cells (PBMCs) of patients with previous HIV/hepatitis C co-infection. HIV Medicine, 10 (suppl 1) 11-56)
'Hepatitis C viral loads in seminal plasma during acute hepatitis C', Dr Joanna Turner, Mortimer Market Centre, London PUBLISHED Hepatitis C viral load in semen of HIV-positive men during acute and chronic hepatitis C infection. HIV Medicine, 11 (Supp 1) 1-19)
'The role of gut mucosa in protection from HIV', Dr Julie Fox, Imperial College of Science, Technology and Medicine, London PUBLISHED The role of the gut mucosa in protection from HIV-1 in highly exposed persistently seronegative individual (HEPS). HIV Medicine, 10 (suppl 1) 1-10)
'The problems that patients bring to HIV clinical services in East London – what are they and how can they best be managed?' Dr Natalie Friend-du Preez, Homerton University Hospital NHS Foundation Trust, London PUBLISHED 'I don't have fear go die, but I have fear don't have money'. When the health needs of HIV patients are overshadowed by their social needs. HIV Medicine, 9 (Suppl 1) 10-50)